197 related articles for article (PubMed ID: 10397712)
1. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases.
Mauro FR; Foa R; Giannarelli D; Cordone I; Crescenzi S; Pescarmona E; Sala R; Cerretti R; Mandelli F
Blood; 1999 Jul; 94(2):448-54. PubMed ID: 10397712
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features.
Mauro FR; Foa R; Cerretti R; Giannarelli D; Coluzzi S; Mandelli F; Girelli G
Blood; 2000 May; 95(9):2786-92. PubMed ID: 10779422
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.
Keating MJ; O'Brien S; Lerner S; Koller C; Beran M; Robertson LE; Freireich EJ; Estey E; Kantarjian H
Blood; 1998 Aug; 92(4):1165-71. PubMed ID: 9694704
[TBL] [Abstract][Full Text] [Related]
4. Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases.
Molica S; Brugiatelli M; Callea V; Morabito F; Levato D; Nobile F; Alberti A
Eur J Haematol; 1994 Apr; 52(4):216-21. PubMed ID: 8005231
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
6. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
Mauro FR; Galieni P; Tedeschi A; Laurenti L; Del Poeta G; Reda G; Motta M; Gozzetti A; Murru R; Caputo MD; Campanelli M; Frustaci AM; Innocenti I; Raponi S; Guarini A; Morabito F; Foà R; Gentile M
Am J Hematol; 2017 Jun; 92(6):529-535. PubMed ID: 28295527
[TBL] [Abstract][Full Text] [Related]
8. Chronic lymphocytic leukemia in Turkey: experience of a single center in Istanbul.
Pamuk ON; Pamuk GE; Soysal T; Ongören S; Başlar Z; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
South Med J; 2004 Mar; 97(3):240-5. PubMed ID: 15043330
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
[TBL] [Abstract][Full Text] [Related]
10. A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.
Rogers KA; Huang Y; Ruppert AS; Salem G; Stephens DM; Heerema NA; Andritsos LA; Awan FT; Byrd JC; Flynn JM; Maddocks KJ; Jones JA
Br J Haematol; 2018 Jan; 180(2):259-266. PubMed ID: 29193006
[TBL] [Abstract][Full Text] [Related]
11. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults.
Montserrat E; Gomis F; Vallespí T; Ríos A; Romero A; Soler J; Alcalá A; Morey M; Ferrán C; Díaz-Mediavilla J
Blood; 1991 Sep; 78(6):1545-51. PubMed ID: 1884021
[TBL] [Abstract][Full Text] [Related]
12. Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States.
Nabhan C; Mato A; Flowers CR; Grinblatt DL; Lamanna N; Weiss MA; Davids MS; Swern AS; Bhushan S; Sullivan K; Flick ED; Kiselev P; Sharman JP
BMC Cancer; 2017 Mar; 17(1):198. PubMed ID: 28302090
[TBL] [Abstract][Full Text] [Related]
13. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
[TBL] [Abstract][Full Text] [Related]
14. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine.
Robak T; Blonski JZ; Gora-Tybor J; Kasznicki M; Konopka L; Ceglarek B; Komarnicki M; Lewandowski K; Hellmann A; Lewandowski K; Moskwa A; Dmoszyńska A; Sokołowska B; Dwilewicz-Trojaczek A; Tomaszewska A; Sułek K; Całbecka M
Eur J Cancer; 2004 Feb; 40(3):383-9. PubMed ID: 14746857
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcome of familial chronic lymphocytic leukemia.
Mauro FR; Giammartini E; Gentile M; Sperduti I; Valle V; Pizzuti A; Guarini A; Giannarelli D; Foà R
Haematologica; 2006 Aug; 91(8):1117-20. PubMed ID: 16885053
[TBL] [Abstract][Full Text] [Related]
16. First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
Meunier G; Ysebaert L; Nguyen-Thi PL; Lepretre S; Quinquenel A; Dupuis J; Lemal R; Aurran T; Tomowiak C; Cymbalista F; Dilhuydy MS; Brion A; Morel P; Cazin B; Leblond V; Cartron G; Ré D; Béné MC; Michallet AS; Feugier P
Hematol Oncol; 2017 Dec; 35(4):671-678. PubMed ID: 27878835
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
[TBL] [Abstract][Full Text] [Related]
18. Disease characteristics and clinical outcomes in patients aged less than 40 with chronic lymphocytic leukemia.
Getta BM; Devlin S; Park JH; Tallman MS; Berman E
Leuk Res; 2018 Feb; 65():80-85. PubMed ID: 29316456
[TBL] [Abstract][Full Text] [Related]
19. Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study.
Kabadi SM; Near A; Wada K; Burudpakdee C
Adv Ther; 2020 Jul; 37(7):3129-3148. PubMed ID: 32399812
[TBL] [Abstract][Full Text] [Related]
20. Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.
Dhodapkar M; Tefferi A; Su J; Phyliky RL
Leukemia; 1993 Aug; 7(8):1232-5. PubMed ID: 8350623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
